Urothelial Cancers

• Bladder and Renal Cell Cancer
• Introduction
• Case presentation: Second-line treatment for bladder cancer
• Advanced Urinary Cancer (Renal and Bladder)
• Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
• Gastric and colorectal
• Bladder cancer
• Molecular sub-types and implications for prognosis and therapy
• Lymph node dissection: How high is enough?
• Bladder preservation: How and for whom?
• JAVELIN Points To Further Avelumab Investigation For Metastatic Urothelial Carcinoma
• PD-L1 in Cancer: ESMO Biomarker Factsheet
• Adjuvant Chemotherapy Plus Radiotherapy Benefits Reported For Locally Advanced Bladder Cancer
• GU (prostate, bladder)
• Oncological outcomes of neoadjuvant chemotherapy in patients with locally advanced upper tract urothelial carcinoma: a multicenter study (272O)
• MECA79 positive high endothelial venule density (HEV) correlates with clinical outcomes in Upper Tract Urothelial Carcinoma patients treated with R...
• The Evaluation and Outcome of A New Intravesical BCG Protocol For Non-muscle Invasive Bladder Cancer In A Tertiary Care Center In India (280P)
• S-1 plus cisplatin combination therapy in patients with urachal carcinoma; a retrospective study (282P)
• High-throughput proteome identifies ANHAK as a novel biomarker for bladder urothelial carcinoma diagnosis in liquid-based cytology. (27P)
• Intravesicle therapy in early bladder cancer: immunotherapy to the fore again
• Bladder Cancer and Renal Cell Cancer
• Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial.
• ESMO 2017 Highlights in Genitourinary Cancers: Treatment Advances
• Loss of SWI/SNF chromatin remodelling complex is linked to advanced urinary bladder cancer
• The role of vitamin D receptor polymorphisms in predicting response to therapy in non-muscle invasive bladder carcinoma

• « Previous
• 1
• 2
• ...
• 10
• Next »